US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, <i>ESR1</i>-Mutated Advanced or Metastatic Breast Cancer
Stemline Therapeutics, Inc.
Mirat Shah; Hima Lingam; Xin Gao; Haley Gittleman; Mallorie H Fiero; Danielle Krol; Nikolett Biel; Tiffany K Ricks; Wentao Fu; Salaheldin Hamed; Fang Li; Jillian Jielin Sun; Jianghong Fan; Robert Schuck; Manuela Grimstein; Liuya Tang; Shyam Kalavar; Abdelrahmman Abukhdeir; Anand Pathak; Soma Ghosh; Ilynn Bulatao; Amy Tilley; William F Pierce; Bronwyn D Mixter; Shenghui Tang; Richard Pazdur; Paul Kluetz; Laleh Amiri-Kordestani